Publication | Open Access
Mutated GM‐CSF‐based CAR‐T cells targeting CD116/CD131 complexes exhibit enhanced anti‐tumor effects against acute myeloid leukaemia
25
Citations
45
References
2021
Year
GMR CAR-T cell therapy represents a promising strategy for CD116<sup>+</sup> R/R AML.
| Year | Citations | |
|---|---|---|
Page 1
Page 1